Looming on the horizon is a major ethical question: If and when we get an effective vaccine for the coronavirus, how should we prioritize distribution? Already public surveys indicate considerable disagreement on who should be at the top of the list, but those surveys have all focused on distribution here in the United States. In a thought-provoking column in The Washington Post this morning, Michael Gerson argued that we need a global approach.

The column, which you’ll find here, is well worth your time.